Short- versus long-term duration of dual antiplatelet therapy in patients treated for in-stent restenosis: A prodigy trial substudy (prolonging dual antiplatelet treatment after grading stent-induced intimal hyperplasia)

Journal of the American College of Cardiology

Volumn 63, Issue 6, 2014, Pages 506-512

  Campo, Gianluca ^a,b   Tebaldi, Matteo ^a   Vranckx, Pascal ^c   Biscaglia, Simone ^a   Tumscitz, Carlo ^a   Ferrari, Roberto ^a,d   Valgimigli, Marco ^a  

^a Cardiovascular Institute   (Italy)

^b Laboratorio per le Tecnologie delle Terapie Avanzate   (Italy)

^c VIRGA JESSE HOSPITAL   (Belgium)

^d IRCCS   (Italy)

Author keywords

aspirin; clopidogrel; drug eluting stent(s); dual antiplatelet therapy; in stent restenosis; percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

AGED; ARTICLE; BLEEDING; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; TREATMENT DURATION; TREATMENT OUTCOME;

ASPIRIN; CLOPIDOGREL; DRUG ELUTING STENT(S); DUAL ANTIPLATELET THERAPY; IN-STENT RESTENOSIS; PERCUTANEOUS CORONARY INTERVENTION;

AGED; AGED, 80 AND OVER; ASPIRIN; CORONARY RESTENOSIS; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; STROKE; TICLOPIDINE;

EID: 84893861327     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.09.043     Document Type: Article

References (20)

1. G. Campo, F. Saia, and P. Guastaroba et al. Prognostic impact of hospital readmissions after primary percutaneous coronary intervention Arch Intern Med 171 2011 1948 1949
2. S.B. King 3rd, S.C. Smith Jr., and J.W. Hirshfeld Jr. et al. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 51 2008 172 209
3. M. Pfisterer, H.P. Brunner-La Rocca, and P.T. Buser et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents J Am Coll Cardiol 48 2006 2584 2591 (Pubitemid 44881238)
4. M. Valgimigli, G. Campo, and M. Monti et al. Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial Circulation 125 2012 2015 2026
5. M. Valgimigli, G. Campo, and G. Percoco et al. Randomized comparison of 6-versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention: design and rationale for the PROlonging Dualantiplatelet treatment after Grading stent-induced Intimal hyperplasia study (PRODIGY) Am Heart J 160 2010 804 811
6. M. Valgimigli, M. Borghesi, and M. Tebaldi et al. Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY) Eur Heart J 34 2013 909 919
7. D.E. Cutlip, S. Windecker, and R. Mehran et al. Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
8. TIMI Study Group The Thrombolysis In Myocardial Infarction (TIMI) trial. Phase I findings N Engl J Med 312 1985 932 936
9. V.L. Serebruany, and D. Atar Assessment of bleeding events in clinical trials: proposal of a new classification Am J Cardiol 99 2007 288 290 (Pubitemid 46072771)
10. R. Mehran, S.V. Rao, and D.L. Bhatt et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium Circulation 123 2011 2736 2747
11. K. Thygesen, J.S. Alpert, and H.D. White et al. Universal definition of myocardial infarction Circulation 116 2007 2634 2653 (Pubitemid 350182388)
12. G.D. Dangas, B.E. Claessen, A. Caixeta, E.A. Sanidas, G.S. Mintz, and R. Mehran In-stent restenosis in the drug-eluting stent era J Am Coll Cardiol 56 2010 1897 1907
13. G.J. Mishkel, A.L. Moore, S. Markwell, M.C. Shelton, and M.E. Shelton Long-term outcomes after management of restenosis or thrombosis of drug-eluting stents J Am Coll Cardiol 49 2007 181 184 (Pubitemid 46054395)
14. S.J. Park, D.W. Park, and Y.H. Kim et al. Duration of dual antiplatelet therapy after implantation of drug-eluting stents N Engl J Med 362 2010 1374 1382
15. T. Tada, M. Natsuaki, and T. Morimoto et al. Duration of dual antiplatelet therapy and long-term clinical outcome after coronary drug-eluting stent implantation: landmark analyses from the CREDO-Kyoto PCI/CABG Registry Cohort-2 Circ Cardiovasc Interv 5 2012 381 391
16. S.R. Mulukutla, O.C. Marroquin, and H.A. Vlachos et al. Benefit of long-term dual anti-platelet therapy in patients treated with drug-eluting stents: from the NHLBI dynamic registry Am J Cardiol 111 2013 486 492
17. D.P. Faxon, E. Lawler, M. Young, M. Gaziano, and S. Kinlay Prolonged clopidogrel use after bare metal and drug-eluting stent placement: the Veterans Administration drug-eluting stent study Circ Cardiovasc Interv 5 2012 372 380
18. D.L. Bhatt, K.A. Fox, and W. Hacke et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events N Engl J Med 354 2006 1706 1717
19. S.D. Wiviott, E. Braunwald, and D.J. Angiolillo et al. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38 Circulation 118 2008 1626 1636
20. G. Montalescot, S.D. Wiviott, E. Braunwald TRITON-TIMI 38 Investigators Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial Lancet 373 2009 723 731